Article Information
History
- December 17, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jean-Baptiste Dupont1,
- Jianjun Guo3,7,
- Michael W. Lawlor4,
- Robert W. Grange5,
- John T. Gray3,
- Ana Buj-Bello6,
- Martin K. Childers1,8 and
- David L. Mack1,2,*
- 1Departments of Rehabilitation Medicine, Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.
- 2Department of Bioengineering, University of Washington, Seattle, WA 98109, USA.
- 3Audentes Therapeutics, San Francisco, CA 94108, USA.
- 4Department of Pathology and Laboratory Medicine and Neuroscience Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
- 5Department of Human Nutrition, Foods, and Exercise, Virginia Polytechnic Institute and State University, Blacksburg, VA 24060, USA.
- 6Généthon, INSERM UMR S951, Université Evry Val-d’Essone, Université Paris-Saclay, 91000 Evry, France.
- 7Present address: Clinical NGS Group, Thermo Fisher Scientific, South San Francisco, CA 94080, USA.
- 8Present address: AskBio, Chapel Hill, NC 27514, USA.
- ↵*Corresponding Author: dmack21{at}uw.edu
Posted December 17, 2018.
AAV-mediated gene transfer restores a normal muscle transcriptome in a canine model of X-linked myotubular myopathy
